Drug Resistance in Leukemia and Lymphoma III: 457 (Advances in Experimental Medicine and Biology, 457) - Image 1

£172.55

Springer Drug Resistance in Leukemia and Lymphoma III: 457 (Advances in Experimental Medicine and Biology, 457)

Name: Drug Resistance in Leukemia and Lymphoma III: 457 (Advances in Experimental Medicine and Biology, 457)
Brand: Springer
Price: 172.55 GBP
Availability: InStock

Oncology

About as cheap as it gets. The only time it was cheaper was 3 months ago.

£173 today · all-time low £173 (Apr 2026) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 53 days · 53 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 53 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £175 (45 days, 84.9%)

Price range: £173 - £175

Price levels: 2 different prices over 53 days

Description

Cellular drug resistance is a major limitation to the success of chemotherapy of leu kemia and lymphoma. The importance of this has now been recognized by both clinicians and scientists. It is of utmost importance to bridge the gap between laboratory and clinic in this field of research. This is the main purpose of the series of International Symposia on Drug Resistance in Leukemia and Lymphoma. These are held every three years in Am sterdam, The Netherlands, since 1992. This book contains the proceedings of the third of these meetings, organised in 1998. The book covers all important aspects of drug resistance in leukemia and lymphoma, both in the form of extensive reviews as in manuscripts describing original data. General mechanisms of resistance are discussed, including the drug resistance related proteins p glycoprotein, MRP (multi-drug resistance protein) and LRP (lung resistance protein), and the role of glutathione and glutathione-S-transferases. Moreover, more drug type-specific mechanisms of resistance are a topic, such as for glucocorticoids and antifolates. Much in formation is provided on apoptosis and its regulators, and on the results of cell culture drug resistance assays. Several papers focus on the modulation or circumvention of drug resistance.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 0306460556
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 30 September 1999
Listed Since: 14 December 2006

Barcode

No barcode data available

Springer Drug Resistance in Leukemia and Lymphoma III: 457 (Advances in Experimental Medicine and Biology, 457)

About as cheap as it gets. The only time it was cheaper was 3 months ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Springer - Drug Resistance in Leukemia and Lymphoma III

Innovative Leukemia and Lymphoma Therapy: 35 (Basic and Clinical Oncology)

Anticancer Drug Resistance: Advances in Molecular and Clinical Research: 73 (Cancer Treatment and Research, 73)

Chemotherapy for Leukemia: Novel Drugs and Treatment

Frontiers in Leukemia Pharmacotherapy

Minimal Residual Disease in Acute Leukemia 1986: 45 (Developments in Oncology, 45)

Cancer Cell Chemoresistance And Chemosensitization

Drug Resistance in Cancer Cells

Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)

Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Chronic and Acute Leukemias in Adults: 26 (Cancer Treatment and Research, 26)

Leukemias

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Drug Resistant Neoplasms (Cancer Etiology Diagnosis and Treatment Series)

Consulting Hematology and Oncology Handbook

Progress in Cancer Drug Resistance Research

Leukemia Stem Cells in Hematologic Malignancies: 1143 (Advances in Experimental Medicine and Biology, 1143)

Springer Hematologic Cancers: Molecular Pathobiology to Therapy

Small Molecules in Oncology: 211 (Recent Results in Cancer Research, 211)

Small Molecules in Oncology: 211 (Recent Results in Cancer Research, 211)

Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)